Mariana Lagrutta

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Vasculitis in Systemic Lupus Erythematosus

Manuel Ramos‐Casals, Norma Nardi, Mariana Lagrutta et al. · Medicine · 2006 · 209 citations

Rheumatology, Current Study, Autoimmune Disease +15

Clinical Features Related to Antiphospholipid Syndrome in Patients with Chronic Viral Infections (Hepatitis C Virus/HIV Infection): Description of 82 Cases

Manuel Ramos‐Casals, Ricard Cervera, Mariana Lagrutta et al. · Clinical Infectious Diseases · 2004 · 77 citations · Full text

Thrombosis, Peripheral Thrombosis, Vasculitis +13

A multicenter prospective study of 515 febrile neutropenia episodes in Argentina during a 5-year period

Roberto Parodi, Mariana Lagrutta, Mauro Tortolo et al. · PLoS ONE · 2019 · 36 citations · Full text

Better Management, Mascc Criteria, Febrile Neutropenia Episodes +13